Citations (32)
Keep up to date with the latest research on this topic with citation updates for this article.
Articles from other publishers (32)
Simone Badal, William Aiken, Belinda Morrison, Henkel Valentine, Sophia Bryan, Andrew Gachii & Camille Ragin. (2019) Disparities in prostate cancer incidence and mortality rates: Solvable or not?. The Prostate 80:1, pages 3-16.
Crossref
Crossref
Monika Toma, Tomasz Skorski & Tomasz Sliwinski. (2019) DNA Double Strand Break Repair - Related Synthetic Lethality. Current Medicinal Chemistry 26:8, pages 1446-1482.
Crossref
Crossref
Philipp Y Maximov, Balkees Abderrahman, Ramona F Curpan, Yousef M Hawsawi, Ping Fan & V Craig Jordan. (2018) A unifying biology of sex steroid-induced apoptosis in prostate and breast cancers. Endocrine-Related Cancer 25:2, pages R83-R113.
Crossref
Crossref
Polly Gravells, Emma Grant, Kate M. Smith, Dominic I. James & Helen E. Bryant. (2017) Specific killing of DNA damage-response deficient cells with inhibitors of poly(ADP-ribose) glycohydrolase. DNA Repair 52, pages 81-91.
Crossref
Crossref
G. C. Shukla, A. R. Plaga, E. Shankar & S. Gupta. (2016) Androgen receptor‐related diseases: what do we know?. Andrology 4:3, pages 366-381.
Crossref
Crossref
Shifalika Tangutoori, Paige Baldwin & Srinivas Sridhar. (2015) PARP inhibitors: A new era of targeted therapy. Maturitas 81:1, pages 5-9.
Crossref
Crossref
Jingxuan Shan, Khalid Al-Rumaihi, Danny Rabah, Issam Al-Bozom, Dhanya Kizhakayil, Karim Farhat, Sami Al-Said, Hala Kfoury, Shoba P Dsouza, Jillian Rowe, Hanif G Khalak, Shahzad Jafri, Idil I Aigha & Lotfi Chouchane. (2013) Genome scan study of prostate cancer in Arabs: identification of three genomic regions with multiple prostate cancer susceptibility loci in Tunisians. Journal of Translational Medicine 11:1.
Crossref
Crossref
Henning Willers, Heike N. Pfäffle & Lee Zou. 2012. DNA Repair in Cancer Therapy. DNA Repair in Cancer Therapy
119
160
.
Laura Fachal, Antonio Gómez‐Caamaño, Catuxa Celeiro‐Muñoz, Paula Peleteiro, Ana Blanco, Ana Carballo, Jerónimo Forteza, Ángel Carracedo & Ana Vega. (2011)
BRCA1
mutations do not increase prostate cancer risk: Results from a meta‐analysis including new data
. The Prostate 71:16, pages 1768-1779.
Crossref
Crossref
Guo-Fang Ding, Yin-Feng Xu, Zui-Su Yang, Yi-Lin Ding, Hai-Fei Fang & Hong-Ping Zhao. (2011) Coexpression of the mutated BRCA1 mRNA and p53 mRNA and its association in Chinese prostate cancer. Urologic Oncology: Seminars and Original Investigations 29:2, pages 145-149.
Crossref
Crossref
Jin-xue He, Chun-hao Yang & Ze-hong Miao. (2010) Poly(ADP-ribose) polymerase inhibitors as promising cancer therapeutics. Acta Pharmacologica Sinica 31:9, pages 1172-1180.
Crossref
Crossref
Regina Berretta & Pablo Moscato. (2010) Cancer Biomarker Discovery: The Entropic Hallmark. PLoS ONE 5:8, pages e12262.
Crossref
Crossref
Hagit Schayek, Itay Bentov, Shihua Sun, Stephen R. Plymate & Haim Werner. (2010) Progression to metastatic stage in a cellular model of prostate cancer is associated with methylation of the androgen receptor gene and transcriptional suppression of the insulin-like growth factor-I receptor gene. Experimental Cell Research 316:9, pages 1479-1488.
Crossref
Crossref
Ethan M. Lange. 2010. Male Reproductive Cancers. Male Reproductive Cancers
203
228
.
Henry T. Lynch, Joseph N. Marcus, J.ane. Lynch, Carrie L. Snyder & Wendy S. Rubinstein. 2009. The Breast. The Breast
371
415
.
Yen‐Ching Chen, John H. Page, Rong Chen & Edward Giovannucci. (2008) Family history of prostate and breast cancer and the risk of prostate cancer in the PSA era. The Prostate 68:14, pages 1582-1591.
Crossref
Crossref
Noah M HahnMark R KelleyJames E KlaunigMichael O KochLang LiChristopher J Sweeney. (2007) Constitutional polymorphisms of prostate cancer: prognostic and diagnostic implications. Future Oncology 3:6, pages 665-682.
Crossref
Crossref
Gustavo Baldassarre, Barbara Belletti, Sabrina Battista, Milena S Nicoloso, Francesca Pentimalli, Monica Fedele, Carlo M Croce & Alfredo Fusco. (2005) HMGA1 protein expression sensitizes cells to cisplatin-induced cell death. Oncogene 24:45, pages 6809-6819.
Crossref
Crossref
W. Krause. (2004) Review article Male breast cancer - an andrological disease: risk factors and diagnosis. Andrologia 36:6, pages 346-354.
Crossref
Crossref
Zhihui Feng, Lisa Kachnic, Junran Zhang, Simon N. Powell & Fen Xia. (2004) DNA Damage Induces p53-dependent BRCA1 Nuclear Export. Journal of Biological Chemistry 279:27, pages 28574-28584.
Crossref
Crossref
R.G. Uzzo, J.G. Brown, E.M. Horwitz, A. Hanlon, S. Mazzoni, A. Konski, R.E. Greenberg, A. Pollack, V. Kolenko & D. Watkins-Bruner. (2004) Prevalence and patterns of self-initiated nutritional supplementation in men at high risk of prostate cancer. BJU International 93:7, pages 955-960.
Crossref
Crossref
Cynthia A. Heinlein & Chawnshang Chang. (2004) Androgen Receptor in Prostate Cancer. Endocrine Reviews 25:2, pages 276-308.
Crossref
Crossref
Judith A. Finlay, Stephen D. Mikolajczyk, Thomas M. Pribyl, R. Bruce Wallace & Harry G. Rittenhouse. 2004. Cancer Diagnostics. Cancer Diagnostics
85
128
.
Jean J Latimer, Tariq Nazir, Lisa C Flowers, Michael J Forlenza, Kelly Beaudry-Rodgers, Crystal M Kelly, Julie A Conte, Kenneth Shestak, Amal Kanbour-Shakir & Stephen G Grant. (2003) Unique tissue-specific level of DNA nucleotide excision repair in primary human mammary epithelial cultures. Experimental Cell Research 291:1, pages 111-121.
Crossref
Crossref
Robert G Uzzo, Wayne H Pinover, Eric M Horwitz, Alicia Parlanti, Susan Mazzoni, Susan Raysor, Ila Mirchandani, Richard E Greenberg, Alan Pollack, Gerald E Hanks & Deborah Watkins-Bruner. (2003) Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digitalrectal examination. Urology 61:4, pages 754-759.
Crossref
Crossref
S.-R. Li, Sina Dorudi & S. A. Bustin. (2003) Identification of Differentially Expressed Genes Associated with Colorectal Cancer Liver Metastasis. European Surgical Research 35:4, pages 327-336.
Crossref
Crossref
Paul Matthew Yonover, Ellen Gaynor & Steven C. Campbell. 2003. Prostate Cancer. Prostate Cancer
159
166
.
Agnes B. Baffoe‐Bonnie, Lambertus A.L.M. Kiemeney, Terri H. Beaty, Joan E. Bailey‐Wilson, Audrey H. Schnell, Helgi Sigvaldason, Guriur Ólafsdóttir, Laufey Tryggvadóttir & Hrafn Tulinius. (2002) Segregation analysis of 389 Icelandic pedigrees with Breast and prostate cancer. Genetic Epidemiology 23:4, pages 349-363.
Crossref
Crossref
OLA BRATT. (2002) Hereditary Prostate Cancer: Clinical Aspects. The Journal of Urology, pages 906-913.
Crossref
Crossref
Ola Bratt. (2002) Hereditary Prostate Cancer: Clinical Aspects. The Journal of Urology 168:3, pages 906-913.
Crossref
Crossref
Stephen J Elledge & Angelika Amon. (2002) The BRCA1 suppressor hypothesis: An explanation for the tissue-specific tumor development in BRCA1 patients. Cancer Cell 1:2, pages 129-132.
Crossref
Crossref
V. Albert Cuñat & E. Maestro Castelblanque. (2002) Cáncer de próstata. SEMERGEN - Medicina de Familia 28:6, pages 315-323.
Crossref
Crossref